A Comprehensive Board Review in Hematology and Medical Oncology - 2026

1. Apply knowledge gained to prepare for the hematology and medical oncology subspecialty and recertification examinations in hematology and medical oncology.
2. Utilize current standards of care for patients with cancer, blood disorders and malignancies.
3. Demonstrate proficiency of knowledge in hematology and medical oncology.
4. Incorporate recent advances in management of hematologic and oncologic patients.

A Virtual Live Streaming Course

The Comprehensive Board Review in Hematology and Medical Oncology will be virtual. This program will be presented only as a live streaming course.

PLANNING COMMITTEE
MD Anderson Cancer Center
Sharon Giordano, MD, MPH, Co-Director
Tapan Kadia, MD, Co-Director
Shreyaskumar Patel, MD
Alessandra Ferrajoli, MD
Nishin Bhadka, MD
Felisha Estelle

Baylor College of Medicine
Martha Mims, MD, PhD, Co-Director

PRESENTATIONS
Course syllabus will not be printed. Presentations (slides) will be available online via the course platform and Canvas. The PowerPoint presentations will be posted online as PDFs prior to the conference. You will receive an invitation email with directives to log in Canvas.

• The Full Conference and Oncology Session will begin at 7:30 a.m. (CDT) on Monday, September 14.  The Oncology Session will adjourn at 12:00 p.m. on Friday, September 18.  The Full Conference will adjourn at 5:00 p.m. on Saturday, September 19.

• The Hematology Session will begin at 7:30 a.m. (CDT) on Thursday, September 17 and adjourn at 5:00 p.m. on Saturday, September 19.

Advanced registration is encouraged.  Please see the registration fees below.

*NOTE: The conference registration fee includes the tuition, access to course virtual platform with PDFs of the slides and Canvas - online web-based system with recorded videos.

The early bird registration deadline is Monday, August 24, 2026.

Telephone registrations are not accepted.

We accept the following forms of payment:

• Credit Cards (MasterCard, VISA, and American Express)

• Check (payable through U.S. banks only)

• Mail to: Continuing Professional Education – Unit 1781, The University of Texas MD Anderson Cancer Center, P.O. Box 301407, Houston, TX 77230-1407

Make check payable to:  The University of Texas MD Anderson Cancer Center

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.

REFUND/CANCELLATION POLICY
The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before Monday, August 24, 2026.  No refunds will be granted after that date.  The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.  For additional information, contact Continuing Professional Education at 713-792-2223 or toll free at 866-849-5866.

Continuing Professional Education reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.

In case of activity cancellation, the liability of Continuing Professional Education is limited to the registration fee.  Continuing Professional Education will refund the full registration fee.

Continuing Professional Education reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

Please let us know what specific topics, issues, or questions you wish to see addressed or emphasized in this activity by emailing Continuing Professional Education at [email protected]. All responses will be forwarded to the Program Directors for consideration.

EVALUATION
An online course evaluation tool will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

SPECIAL ASSISTANCE
Contact Felisha Estelle in Continuing Professional Education at 713-745-0083 or 1-866-531-MOBR (6627) if you have any ADA accommodation needs.

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 51.25 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 Maintenance of Certification

American Board of Internal Medicine (ABIM)
Successful completion of this CE activity, which includes participation in the evaluation component, enables the participant to earn up to 51.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CE credits claimed for the activity. It is the CE activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

In order to receive MOC points, you must pass the post-test with a score of 70% or higher.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf. 

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Sharon H. Giordano, MD, FASCO
Professor
The University of Texas MD Anderson Cancer Center

Activity Co-Director, Content Reviewer, Faculty

Nothing to disclose

Tapan M. Kadia, MD
Professor
The University of Texas MD Anderson Cancer Center

Activity Co-Director, Faculty

Grant or research support-Bristol-Myers Squibb Company|Honoraria-DAVA Oncology|Speakers Bureau-CURE|Honoraria-DrenBio|Grant or research support-Dren Bio|Grant or research support-Celgene Corporation (Relationship has ended)|Grant or research support-BMS|Honoraria-Biologix (Relationship has ended)|Grant or research support-Janssen Biotech, Inc. (Relationship has ended)|Grant or research support-Incyte Corporation|Grant or research support-Astex|Grant or research support-Abcuro|Grant or research support-Pfizer Inc.|Honoraria-Hikma Pharmaceuticals|Consulting Fee-Genzyme Corporation (Relationship has ended)|Grant or research support-Glycomimetics|Consulting Fee-Sellas|Grant or research support-Sellas|Grant or research support-AbbVie Inc.|Grant or research support-Amgen Inc. (Relationship has ended)|Grant or research support-Genentech, Inc.|Grant or research support-Ascentage|Grant or research support-Cellenkos (Relationship has ended)|Grant or research support-AstraZeneca US (Relationship has ended)|Grant or research support-Astellas Scientific and Medical Affairs, Inc. (Relationship has ended)|Paid consultant-AbbVie Inc.|Paid consultant-Genentech, Inc.|Grant or research support-Genfleet|Grant or research support-Sellas, Inc|Grant or research support-Delta Fly Pharma (Relationship has ended)|Grant or research support-Jazz Pharmaceuticals|Paid consultant-Jazz Pharmaceuticals|Paid consultant-Novartis Pharmaceuticals Corporation|Paid consultant-Daiichi Sankyo, Inc.|Paid consultant-Agios Pharmaceuticals Inc.|Consulting Fee-PinotBio (Relationship has ended)|Consulting Fee-Sanofi US (Relationship has ended)|Paid consultant-Pfizer Inc.|Grant or research support-Regeneron Pharmaceuticals, Inc.|Consulting Fee-Servier Pharmaceuticals|Consulting Fee-Syndax|Consulting Fee-Kura

Martha Mims, MD, PhD
Professor and Section Chief, Hematology/Oncology
Baylor College of Medicine

Activity Co-Director, Faculty

Stocks or stock options, excluding diversified mutual funds-Amgen Inc.|Stocks or stock options, excluding diversified mutual funds-Biogen Inc.|Grant or research support-Janssen Biotech, Inc. (Relationship has ended)|Grant or research support-Celgene Corporation (Relationship has ended)|Grant or research support-Incyte Corporation (Relationship has ended)|Grant or research support-inovio

Teresa Moon, MD
MD Anderson Cancer Center

CE Reviewer

Nothing to disclose

Felisha Estelle, BBA
CE Activity Planner
The University of Texas MD Anderson Cancer Center

CPE Planner

Nothing to disclose

Omar Alhalabi, MD
Assistant Professor - Genitourinary Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Seattle Genetics, Inc. (Relationship has ended)|Advisor-Oncodetect (Relationship has ended)|Advisor-Apptitude Health (Relationship has ended)|Consulting Fee-AstraZeneca US (Relationship has ended)|Advisor-Bicycle therapeutics (Relationship has ended)|Grant or research support-Genentech, Inc.|Grant or research support-Ikena (Relationship has ended)|Grant or research support-Arcus|Grant or research support-AstraZeneca US|Consulting Fee-Adaptimmune (Relationship has ended)|Consulting Fee-Cardinal health (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Silverback Therapeutics (Relationship has ended)

Rodabe N. Amaria, MD
Associate Professor, Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty

Grant or research support-Novartis Pharmaceuticals Corporation (Relationship has ended)|Grant or research support-KSQ|Grant or research support-Erasca|Grant or research support-Erasca|Consulting Fee-Obsidian |Grant or research support-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)|Grant or research support-Bristol-Myers Squibb Company (Relationship has ended)|Grant or research support-Regeneron Pharmaceuticals, Inc.|Grant or research support-Iovance (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals Corporation (Relationship has ended)|Grant or research support-Obsidian|Grant or research support-OnKure|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol-Myers Squibb Company (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-TIL Working Group|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Nektar (Relationship has ended)

Kenneth Bauer, MD
Professor
Beth Israel Deaconess Medical Center

Faculty

Consulting Fee-Sanofi US (Relationship has ended)

Alexandre Bazinet, MD
Assistant Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Nancy Berliner, MD
Chief, Division of Hematology
Brigham and Women's Hospital

Faculty

Advisor-Sobi|Advisor-Electra

Abenaa M. Brewster, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Michael D Bruce, MD
Clinical Fellow
Baylor College of Medicine

Faculty

Bradley Carthon, MD, PhD, MD, PhD
Associate Professor
Emory Healthcare

Faculty

Carla Casulo, MD
University of Rochester

Faculty

Honoraria- Mashup Media (Relationship has ended)|Consulting Fee- Mashup Media (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb Company|Honoraria-Bristol-Myers Squibb Company|Consulting Fee-AbbVie Inc.|Honoraria-AbbVie Inc.|Consulting Fee-Genentech, Inc.|Honoraria-Genentech, Inc.|Grant or research support-Genmab|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Genentech, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-FL Cures Foundation (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-American Society of Hematology|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lymphoma Research Foundation|Honoraria-Genmab|Consulting Fee-Genmab

Mariana C. Chavez MacGregor, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Jorge Cortes, MD
O'Neal Cancer Center at the University of Alabama at Birmingham

Faculty

Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-Ascentage|Consulting Fee-Xspray|Consulting Fee-Azurity|Consulting Fee-Johnson & Johnson (any division)|Consulting Fee

Courtney D. DiNardo, MD
Associate Professor
The University of Texas MD Anderson Cancer Center

Faculty

Honoraria-AbbVie Inc.|Honoraria-Syndax|Honoraria-Kura|Honoraria-Rigel|Honoraria-Daiichi Sankyo, Inc.|Honoraria-Genentech, Inc.|Honoraria-Astellas Scientific and Medical Affairs, Inc. (Relationship has ended)|Honoraria-Bristol-Myers Squibb Company|Honoraria-GlaxoSmithKline|Honoraria-Novartis Pharmaceuticals Corporation (Relationship has ended)|Honoraria-Servier Pharmaceuticals|Honoraria-Immunogen (Relationship has ended)|Advisor-Ellipses

Ravin J. Garg, MD
Medical Doctor
Maryland Oncology Hematology/US Oncology and Assistant Professor of Oncology/Johns Hopkins Hospital

Faculty

Nothing to disclose

Carl M. Gay, MD
The University of Texas MD Anderson Cancer Center

Faculty

Advisor-Pharmacosmos (Relationship has ended)|Advisor-Boehringer Ingelheim|Advisor-Amgen Inc. (Relationship has ended)|Advisor-BeOne (Relationship has ended)|Advisor-AstraZeneca US (Relationship has ended)|Advisor-Jazz Pharmaceuticals|Grant or research support-AstraZeneca US|Grant or research support-BioNTech|Grant or research support-IDEAYA|Speakers Bureau-AstraZeneca US (Relationship has ended)|Advisor-Daiichi Sankyo, Inc. (Relationship has ended)|Speakers Bureau-Dava Oncology (Relationship has ended)

Timothy D. Gilligan, MD, FASCO, FACH
Associate Professor & Vice-Chair for Education
Cleveland Clinic Taussig Cancer Institute

Faculty

Nothing to disclose

Betty Hamilton, MD
Cleveland Clinic

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Incyte Corporation|Grant or research support-Angiocrine|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Sanofi US|Membership on Advisory Committees or Review Panels, Board Membership, etc.-CSL Behring|Consulting Fee-T-Scan

Nasser H. Hanna, MD
Professor of Medicine
Indiana University

Faculty

Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Genentech, Inc.

Yvonne J. Heung, MD
Associate Professor
MD Anderson Cancer Center

Faculty

Nothing to disclose

Emily Hinchcliff, MD
Assistant Professor
Northwestern Medicine

Faculty

Speakers Bureau-AbbVie Inc.|Consulting Fee-Merck Research Laboratories and the Office of the Chief Medical Officer Grants

Mimi I. Hu, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Grant or research support-Lilly USA, LLC|Speakers Bureau-Eli Lilly & Co (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lilly USA, LLC

Claudine Isaacs, MD, FRCPC
Professor
Georgetown

Faculty

Consulting Fee-Genentech, Inc.|Consulting Fee-AstraZeneca US|Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-PUMA|Consulting Fee-Pfizer Inc.|Consulting Fee-ION Solutions (Relationship has ended)|Consulting Fee-Gilead Sciences, Inc.|Consulting Fee-Merck Sharp & Dohme Corp. (any division)|Honoraria-Medscape|Honoraria-MJH Holdings|Royalties or Patent Beneficiary-Wolters Kluwer|Royalties or Patent Beneficiary-McGraw Hill|Consulting Fee-Artera|Consulting Fee-Ataraxis|Consulting Fee-Arvinas|Consulting Fee-Boehringer Ingelheim|Grant or research support-QuatumLeap|Other: Editor in Chief-Springer Nature

Inimfon Jackson, MD
MD Anderson Cancer Center

Faculty

Nothing to disclose

Eric Jonasch, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Consulting Fee-Aveo|Grant or research support-Bristol-Myers Squibb Company|Consulting Fee-Bristol-Myers Squibb Company|Grant or research support-ProFoundBio|Grant or research support-AbbVie Inc. (Relationship has ended)|Grant or research support-Calico |Grant or research support-Telix|Consulting Fee-Telix|Grant or research support-Aveo|Grant or research support-Corvus|Consulting Fee-Eisai, Inc.|Honoraria-Exelixis|Honoraria-Ipsen US|Honoraria-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Honoraria-Nikang|Grant or research support-Nikang|Honoraria-Takeda (Relationship has ended)|Honoraria-DAVA

Hagop M. Kantarjian, MD
MD
The University of Texas MD Anderson Cancer Center

Faculty

Grant or research support-AbbVie Inc.|Grant or research support-Amgen Inc.|Grant or research support-Pfizer Inc.|Grant or research support-Takeda|Consulting Fee-AbbVie Inc.|Consulting Fee-Amgen Inc.|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Pfizer Inc.|Consulting Fee-Takeda

Scott Kopetz, MD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty

Stocks or stock options, excluding diversified mutual funds-Lutris Pharmaceuticals (Relationship has ended)|Advisor-Lutris Pharmaceuticals (Relationship has ended)|Consulting Fee-Genentech, Inc.|Grant or research support-EMD Serono Inc.|Consulting Fee-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Novartis Pharmaceuticals Corporation (Relationship has ended)|Grant or research support-Lilly USA, LLC|Consulting Fee-Boehringer Ingelheim|Grant or research support-Boehringer Ingelheim|Consulting Fee-Bayer HealthCare Pharmaceuticals, Inc.|Grant or research support-Daiichi Sankyo, Inc.|Consulting Fee-Pfizer Inc.|Grant or research support-Jazz Pharmaceuticals|Consulting Fee-Mirati Therapeutics|Consulting Fee-Flame Biosciences|Consulting Fee-Carina Biotechnology|Grant or research support-Sanofi US (Relationship has ended)|Grant or research support-Guardant Health|Grant or research support-Genentech, Inc.|Grant or research support-MedImmune (Relationship has ended)|Grant or research support-Amgen Inc.|Consulting Fee-Frontier Medicines|Consulting Fee-Replimune|Consulting Fee-Bristol-Myers Squibb-Medarex|Consulting Fee-Amgen|Consulting Fee-Tempus|Consulting Fee-Harbinger Oncology|Consulting Fee-Zentalis|Consulting Fee-AVEO|Consulting Fee-Tachyon Therapeutics|Consulting Fee-Agenus|Consulting Fee-Revolution Medicines|Consulting Fee-Kestrel Therapeutics|Consulting Fee-Roche|Grant or research support-BridgeBio|Grant or research support-Cardiff|Grant or research support-Zentalis|Grant or research support-Mirati (Relationship has ended)|Consulting Fee-Arcus Biosciences|Consulting Fee-AstraZeneca Pharmaceutical|Consulting Fee-BeiGene|Consulting Fee-Clasp Therapeutics|Consulting Fee-Cytovation|Consulting Fee-Dewpoint Therapeutics|Consulting Fee-Marengo Therapeutics|Consulting Fee- SageMedic|Consulting Fee-Servier|Consulting Fee-Sibylla|Consulting Fee-T-Cypher Bio|Consulting Fee-XAIRA|Consulting Fee-AmMax Bio|Consulting Fee-Ikena|Grant or research support-Pfizer Inc.|Grant or research support-BioMed Valley|Consulting Fee-Arvinas|Consulting Fee-AVEO|Consulting Fee-DeBiopharm|Consulting Fee-Gilead|Consulting Fee- Janssen|Consulting Fee-Kivu|Consulting Fee- Larkspur|Consulting Fee-Menarini Ricerche|Consulting Fee-Pierre Fabre|Consulting Fee-Sanofi|Consulting Fee-Verastem|Grant or research support-Frontier Medicines, |Grant or research support-Johnson & Johnson

Alfred Lee, MD, PhD
Yale School of Medicine

Faculty

Mark Lewis, MD
Intermountain Healthcare

Faculty

Jennifer K. Litton, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Alice Ma, MD
Professor of Medicine
University of North Carolina

Faculty

Consulting Fee-Pfizer Inc. (Relationship has ended)

Claire Mach, PharmD
Clinical Pharmacy Specialist
Harris Health System

Faculty

Nothing to disclose

L. Jeffrey Medeiros, MD
Chair - Hematopathology Adm
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Stephan Moll, MD
UNC Chapel Hill

Faculty

Nothing to disclose

Alison Moskowitz, MD
Memorial Sloan Kettering Cancer Center

Faculty

Other: speaking-Takeda Pharmaceuticals (Relationship has ended)|Advisor-Pfizer Inc.|Grant or research support-Pfizer Inc.|Grant or research support-Incyte Corporation|Grant or research support-Merck Sharp & Dohme Corp. (any division)|Honoraria-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Secura-Bio

Kerry O'Brien, MD
Medical Director Blood Bank
Beth Israel Deaconess Medical Center

Faculty

Nothing to disclose

Susan O'Brien, MD
Professor of Medicine
University of California Irvine

Faculty

Consulting Fee-AbbVie Inc.|Consulting Fee-Regeneron Pharmaceuticals, Inc. (Relationship has ended)|Consulting Fee-Pharmacyclics LLC|Consulting Fee-Johnson & Johnson (any division)|Consulting Fee-Janssen Biotech, Inc.|Consulting Fee-GlaxoSmithKline (Relationship has ended)|Consulting Fee-Genentech, Inc.|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-AstraZeneca US|Grant or research support-Caribou|Consulting Fee-Autolus

Timothy Olson, MD, PhD
Medical Director, Blood and Marrow Transplant Program
Children's Hospital of Philadelphia

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genetix|Consulting Fee-Vertex|Honoraria-Alexion (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Medexus|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Elixergin Therapeutics (Relationship has ended)

Antonio Omuro, MD
Stanford University

Faculty

Consulting Fee-Ono Pharma USA, Inc (Relationship has ended)

Jacquelyn Powers, MD
Associate Professor
Baylor College of Medicine

Faculty

Nothing to disclose

S. Vincent Rajkumar, MD
Professor of Medicine
Mayo Clinic

Faculty

Nothing to disclose

Raajit Rampal, MD, PhD
Associate Member
MSKCC

Faculty

A. Koneti Rao, MD
Lewis Katz School of Medicine

Faculty

Nothing to disclose

Jose A. Rauh-Hain, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center

Faculty

Honoraria-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)

Caitlin R Rausch, PharmD, BCOP
Clinical Pharmacy Specialist
MD Anderson Cancer Center

Faculty

Advisor-Johnson & Johnson (any division) (Relationship has ended)

Bethany T Samuelson Bannow, MD, MCR
Associate Professor
Cleveland Clinic

Faculty

Samuel A. Shelburne III, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Gerald A Soff, MD
Chief, Classical Hematology Service
University of Miami Health System/Sylvester Comprehensive Cancer Center

Faculty

Grant or research support-Sobi Pharmaceuticals|Grant or research support-Anthos Therapeutics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Alpine Immune Sciences, a Vertex Company|Grant or research support-Sanofi Genzyme|Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-Regeneron Pharmaceuticals, Inc.

Paolo Strati, MD
Associate Professor
MD Anderson Cancer Center

Faculty

Consulting Fee-Genentech, Inc.|Advisor-Incyte (Relationship has ended)|Advisor-Sobi (Relationship has ended)|Advisor-ADC Therapeutics (Relationship has ended)|Grant or research support-ADC Therapeutics|Advisor-Kite-Gilead (Relationship has ended)|Grant or research support-Gilead Sciences, Inc.|Advisor-AstraZeneca US (Relationship has ended)|Grant or research support-AstraZeneca US|Grant or research support-ALX Oncology|Advisor-AbbVie Inc.|Advisor-Genmab|Advisor-Ipsen US|Advisor-Novartis Pharmaceuticals Corporation|Consulting Fee-Lilly USA, LLC|Consulting Fee-Merck Sharp & Dohme Corp. (any division)

Kaiwen Wang, PharmD
MD Anderson Cancer Center

Faculty

Advisor-Pfizer Inc. (Relationship has ended)|Advisor-Janssen Biotech, Inc. (Relationship has ended)|Advisor-Bayer HealthCare Pharmaceuticals, Inc.

Jason R. Westin, MD
Dr
MDACC

Faculty

Grant or research support-AstraZeneca US|Grant or research support-Allogene|Paid consultant-Allogene|Paid consultant-AbbVie Inc.|Paid consultant-Nurix|Grant or research support-Nurix|Paid consultant-Pfizer Inc.|Grant or research support-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)|Paid consultant-ADC Therapeutics|Paid consultant-Morphosys|Paid consultant-Novartis Pharmaceuticals Corporation|Paid consultant-Gilead Sciences, Inc.|Paid consultant-Genentech, Inc.|Grant or research support-Johnson & Johnson (any division)|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Morphosys|Grant or research support-Genentech, Inc.

William N. William Jr., MD
Medical Oncologist
Hospital BP
Brazil

Faculty

Consulting Fee-AstraZeneca US|Consulting Fee-Amgen Inc.|Consulting Fee-Bayer HealthCare Pharmaceuticals, Inc.|Consulting Fee-Boehringer Ingelheim|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Janssen Biotech, Inc.|Consulting Fee-Lilly USA, LLC|Consulting Fee-Merck Sharp & Dohme Corp. (any division)|Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-Pfizer Inc.|Consulting Fee-Sanofi Genzyme|Consulting Fee-Genentech, Inc.

Robert A. Wolff, MD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Harry H. Yoon, MD
Associate Professor
Mayo Clinic

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Daiichi Sankyo, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-LSK Biopharma|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Jazz Pharmaceuticals|Other: Educator/Trainer of external academic speakers-Jazz Pharmaceuticals|Grant or research support-BeOne|Grant or research support-Amgen Inc.|Grant or research support-Macrogenics|Grant or research support-Merck Sharp & Dohme Corp. (any division)|Advisor-BeOne|Advisor-Macrogenics|Advisor-Merck Sharp & Dohme Corp. (any division)|Advisor-Amgen Inc.

Shreyaskumar Patel, MD
Professor - Sarcoma Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty, Planning Committee Member

Consulting Fee-Daiichi Sankyo, Inc.|Consulting Fee-Deciphera|Consulting Fee-Kura Oncology|Consulting Fee-Parabilis

Nishin Bhadkamkar, MD
Associate Professor
The University of Texas MD Anderson Cancer Center

Planning Committee Member

Nothing to disclose

Alessandra Ferrajoli, MD
Professor of Medicine
The University of Texas MD Anderson Cancer Center

Planning Committee Member

Membership on Advisory Committees or Review Panels, Board Membership, etc.-AbbVie Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech, Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca US (Relationship has ended)